psoriasis

Here comes the blockbuster: Novartis' Cosentyx bests Stelara in psoriasis trials
BioPharma Dive
Mon, 03/23/15 - 10:36 am
Novartis
Cosentyx
Stelara
psoriasis
Pfizer Announces Oral Tofacitinib Meets Primary Endpoints In Pivotal Phase 3 Psoriasis Trials
Yahoo
Fri, 03/20/15 - 08:28 pm
Pfizer
tofacitinib
psoriasis
Novartis AG (ADR) Cosentyx More Effective Than Johnson & Johnson Stelara
Bidness Etc.
Sat, 03/14/15 - 03:04 pm
Novartis
Cosentyx
Stelara
JNJ
psoriasis
Novartis AG Anticipates Price War With Amgen, Eli Lilly & Co. Over Psoriasis Drugs
Bidness Etc.
Wed, 01/28/15 - 11:31 am
Novartis
Amgen
Eli Lilly
drug pricing
psoriasis
Novartis psoriasis drug approval could upend market
Medical Marketing and Media
Thu, 01/22/15 - 09:55 am
Novartis
psoriasis
Cosentyx
Amgen
Stelara
Enbrel
Novartis Wins U.S. Approval for First of New Psoriasis Drugs
Bloomberg
Wed, 01/21/15 - 05:46 pm
Novartis
FDA
psoriasis
Cosentyx
EU Oks new Celgene pill for psoriasis, psoriatic arthritis
Yahoo/AP
Sat, 01/17/15 - 10:42 am
Celgene
psoriasis
psoriatic arthritis
Is this the future of late-stage drug development? Lets hope so!
Forbes
Mon, 12/15/14 - 10:19 am
R&D
drug development
Stelara
JNJ
psoriasis
Novartis
Cosentyx
Novartis AG and Amgen Inc. Take Aim at Johnson & Johnson
Motley Fool
Mon, 12/15/14 - 08:50 am
Novartis
Amgen
JNJ
Stelara
psoriasis
brodalumab
Cosentyx
Novartis' psoriasis drug tops J&J's Stelara as it speeds toward approval
Fierce Biotech
Fri, 12/12/14 - 08:51 am
Novartis
psoriasis
JNJ
Stelara
secukinumab
Sandoz loses bid to shield psoriasis drug
Yahoo/Reuters
Fri, 12/5/14 - 03:18 pm
Sandoz
psoriasis
Amgen
Enbrel
generics
Amgen, AstraZeneca's brodalumab beats J&J's Stelara in 2nd PhIII psoriasis showdown
Fierce Biotech
Wed, 11/26/14 - 11:38 am
Amgen
AstraZeneca
brodalumab
JNJ
Stelara
psoriasis
Novartis' Enbrel beater bounds toward psoriasis approval ahead of the crowd
Fierce Biotech
Fri, 11/21/14 - 10:30 am
Novartis
Enbrel
psoriasis
Cosentyx
Amgen psoriasis drug tops J&J's Stelara in Phase III study
Yahoo/Reuters
Wed, 11/12/14 - 08:32 am
Amgen
psoriasis
JNJ
brodalumab
Stelara
Benefits of Novartis psoriasis drug outweighs risk: FDA staff
Yahoo/Reuters
Thu, 10/16/14 - 09:19 am
Novartis
psoriasis
FDA
secukinumab
Novartis Says Psoriasis Drug Met End-Goal of Arthritis Studies
Bloomberg
Thu, 09/25/14 - 07:38 am
Novartis
psoriasis
secukinumab
psoriatic arthritis
Celgene Wins U.S. Approval of New Psoriasis Pill
Bloomberg
Tue, 09/23/14 - 04:58 pm
Celgene
psoriasis
FDA
Otezla
Merck licenses experimental psoriasis drug to India's Sun Pharma
Yahoo/Reuters
Wed, 09/17/14 - 04:35 pm
Merck
Sun Pharma
psoriasis
tildrakizumab
India
Big Pharma, Big Biotech prepare for showdown in next-gen psoriasis market
Fierce Pharma Marketing
Wed, 08/27/14 - 10:22 am
Embrel
Amgen
Pfizer
Eli Lilly
Novartis
Celgene
psoriasis
AstraZeneca
Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies
Yahoo
Thu, 08/21/14 - 07:45 am
ixekizumab
etanercept
El Lilly
psoriasis

Pages